305 related articles for article (PubMed ID: 23340708)
1. Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma.
Kaibori M; Kubo S; Nagano H; Hayashi M; Haji S; Nakai T; Ishizaki M; Matsui K; Uenishi T; Takemura S; Wada H; Marubashi S; Komeda K; Hirokawa F; Nakata Y; Uchiyama K; Kwon AH
World J Surg; 2013 Apr; 37(4):820-8. PubMed ID: 23340708
[TBL] [Abstract][Full Text] [Related]
2. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
3. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma.
Hanazaki K; Kajikawa S; Shimozawa N; Mihara M; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
J Am Coll Surg; 2000 Oct; 191(4):381-8. PubMed ID: 11030243
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
5. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
7. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Minagawa M; Makuuchi M; Takayama T; Kokudo N
Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium.
Wakayama K; Kamiyama T; Yokoo H; Kakisaka T; Kamachi H; Tsuruga Y; Nakanishi K; Shimamura T; Todo S; Taketomi A
World J Surg Oncol; 2013 Oct; 11():259. PubMed ID: 24093164
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.
Poon RT; Fan ST; Lo CM; Liu CL; Wong J
Ann Surg; 1999 Feb; 229(2):216-22. PubMed ID: 10024103
[TBL] [Abstract][Full Text] [Related]
10. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients--experience from an Australian hepatobiliary unit.
Chua TC; Saxena A; Chu F; Liauw W; Zhao J; Morris DL
J Gastrointest Surg; 2010 Sep; 14(9):1370-80. PubMed ID: 20585991
[TBL] [Abstract][Full Text] [Related]
13. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
[TBL] [Abstract][Full Text] [Related]
14. Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - A retrospective cohort study.
Blüthner E; Bednarsch J; Malinowski M; Binder P; Pratschke J; Stockmann M; Kaffarnik M
Int J Surg; 2019 Nov; 71():56-65. PubMed ID: 31494333
[TBL] [Abstract][Full Text] [Related]
15. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma.
Sugimachi K; Maehara S; Tanaka S; Shimada M; Sugimachi K
J Hepatobiliary Pancreat Surg; 2001; 8(5):410-6. PubMed ID: 11702249
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the surgical outcomes in patients with synchronous versus metachronous multiple hepatocellular carcinoma.
Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Mitsuka Y; Tsuji S
Biosci Trends; 2021 Jan; 14(6):415-421. PubMed ID: 32999134
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas.
Nagano Y; Shimada H; Ueda M; Matsuo K; Tanaka K; Endo I; Kunisaki C; Togo S
ANZ J Surg; 2009 Oct; 79(10):729-33. PubMed ID: 19878169
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of early hepatocellular carcinoma after hepatic resection.
Maeda T; Shimada M; Harimoto N; Tsujita E; Aishima S; Tanaka S; Shirabe K; Maehara Y
Hepatogastroenterology; 2008; 55(85):1428-32. PubMed ID: 18795705
[TBL] [Abstract][Full Text] [Related]
20. Post-resection recurrence of hepatocellular carcinoma in cirrhotic patients: Is thrombocytopenia a risk factor for recurrence?
Shehta A; Han HS; Ahn S; Yoon YS; Cho JY; Choi YR
Surg Oncol; 2016 Dec; 25(4):364-369. PubMed ID: 27916167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
